Therefore, treatment with antioxidants to prevent chemotherapy-induced melanoma metastasis should be considered in patients using anticancer drugs that target cellular metabolism mediated by the ARNT/PDK1 pathway (Fig. 8). This evidence concerns the gene PDK1 and melanoma.